Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies

Timo Gemoll, Franziska Epping, Lisa Heinrich, Britta Fritzsche, Uwe J Roblick, Silke Szymczak, Sonja Hartwig, Reinhard Depping, Hans-Peter Bruch, Christoph Thorns, Stefan Lehr, Andreas Paech, Jens K Habermann

Abstract

Cancer proteomics provide a powerful approach to identify biomarkers for personalized medicine. Particularly, biomarkers for early detection, prognosis and therapeutic intervention of bone cancers, especially osteosarcomas, are missing. Initially, we compared two-dimensional gel electrophoresis (2-DE)-based protein expression pattern between cell lines of fetal osteoblasts, osteosarcoma and pulmonary metastasis derived from osteosarcoma. Two independent statistical analyses by means of PDQuest® and SameSpot® software revealed a common set of 34 differentially expressed protein spots (p < 0.05). 17 Proteins were identified by mass spectrometry and subjected to Ingenuity Pathway Analysis resulting in one high-ranked network associated with Gene Expression, Cell Death and Cell-To-Cell Signaling and Interaction. Ran/TC4-binding protein (RANBP1) and Cathepsin D (CTSD) were further validated by Western Blot in cell lines while the latter one showed higher expression differences also in cytospins and in clinical samples using tissue microarrays comprising osteosarcomas, metastases, other bone malignancies, and control tissues. The results show that protein expression patterns distinguish fetal osteoblasts from osteosarcomas, pulmonary metastases, and other bone diseases with relevant sensitivities between 55.56% and 100% at ≥87.50% specificity. Particularly, CTSD was validated in clinical material and could thus serve as a new biomarker for bone malignancies and potentially guide individualized treatment regimes.

Original languageEnglish
JournalOncotarget
Volume6
Issue number18
Pages (from-to)16517-26
Number of pages10
DOIs
Publication statusPublished - 30.06.2015

Fingerprint

Dive into the research topics of 'Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies'. Together they form a unique fingerprint.

Cite this